Stockreport

Harvard Bioscience targets $22.5M–$24.5M Q4 revenue as backlog reaches two-year high, expanding product rollouts and distribution [Seeking Alpha]

Harvard Bioscience, Inc.  (HBIO) 
Last harvard bioscience, inc. earnings: 2/26 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investor.harvardbioscience.com
PDF John Duke, President and CEO, reported operational progress and improvements across key areas, stating the company delivered revenue of $20.6 million, which was at the [Read more]